Recursion Pharmaceuticals (RXRX) Cash & Equivalents (2020 - 2026)
Recursion Pharmaceuticals' Cash & Equivalents came in at $545.68 million for Q2 2026, up 3.9% from $525.11 million a year earlier but down 16.6% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Recursion Pharmaceuticals' Cash & Equivalents was $743.29 million, up 25.1% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $594.35 million in FY2024 (+51.8%), $391.57 million in FY2023 (-28.8%), $549.91 million in FY2022 (+92.9%) and $285.12 million in FY2021 (+8.8%).
- The five-year range for quarterly Cash & Equivalents is $285.12 million (Q4 2021) to $743.29 million (Q4 2025).
- Year-over-year, Cash & Equivalents has increased for nine consecutive quarters, with growth averaging 32.0% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2022 (growth of 137.2%), and the weakest in Q1 2024 (a decline of 37.4%).
- Business Quant data shows RXRX's Cash & Equivalents at $654.47 million (Q1 2026), $743.29 million (Q4 2025) and $659.84 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Recursion Pharmaceuticals | 2.21 Bn | -397.37 Mn | -3.82 Mn | 545.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 545.68 Mn |
| Mar 31, 2026 | 654.47 Mn |
| Dec 31, 2025 | 743.29 Mn |
| Sep 30, 2025 | 659.84 Mn |
| Jun 30, 2025 | 525.11 Mn |
| Mar 31, 2025 | 500.45 Mn |
| Dec 31, 2024 | 594.35 Mn |
| Sep 30, 2024 | 427.65 Mn |
| Jun 30, 2024 | 474.34 Mn |
| Mar 31, 2024 | 296.33 Mn |
| Dec 31, 2023 | 391.57 Mn |
| Sep 30, 2023 | 387.32 Mn |
| Jun 30, 2023 | 405.87 Mn |
| Mar 31, 2023 | 473.15 Mn |
| Dec 31, 2022 | 549.91 Mn |
| Sep 30, 2022 | 454.65 Mn |
| Jun 30, 2022 | 453.88 Mn |
| Mar 31, 2022 | 507.89 Mn |
| Dec 31, 2021 | 285.12 Mn |
| Sep 30, 2021 | 394.72 Mn |
API Access
Recursion Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();